IVF_INSPIRE IVF

IVF · BK · Healthcare / Medical Care Facilities

0.56THB-0.02 (-3.45%)

Price History

Full chart

Market Stats

Previous Close0.58

Open0.56

Day Range0.56 – 0.58

52-Week Range0.50 – 1.01

Volume113.20K

Market Cap312.40M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.03

Dividend Yield0.00%

50-Day Avg0.7646

200-Day Avg0.7302

About

Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. It offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. The company provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services. Inspire IVF Public Company Limited was incorporated in 2018 and is based in Bangkok, Thailand.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMs. Kasinee Kuldiloke
Employees0
HeadquartersPloenchit Center Building, Bangkok, Thailand, 10110, Thailand
Websitehttps://www.inspireivf.com

Leadership

Ms. Kasinee KuldilokeActing COO, CEO & Executive Director · b. 1980
Mr. Parama RattanaubonChief Financial Officer · b. 1991
Mr. Sittideth SangnualChief Scientific Officer & Chief Genetics Laboratory Officer · b. 1988
Mr. Chatree SiribunChief Embryology Laboratory Officer
Dr. Bancha KanluanChief Medical & Nursing Officer

Financials

Income Statement

Currency: THB	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	11.24M	63.31M	121.55M	105.70M	61.87M
Growth (%)	-	+463.26%	+91.99%	-13.04%	-41.46%
Cost of Revenue	13.64M	32.27M	42.04M	44.06M	42.92M
Gross Profit	-2.40M	31.04M	79.51M	61.64M	18.96M
Gross Margin	-21.35%	49.03%	65.42%	58.31%	30.64%
Operating Expense	4.47M	17.68M	24.46M	35.43M	44.25M
Operating Income	-6.87M	13.36M	55.05M	26.21M	-25.30M
Operating Margin	-61.12%	21.10%	45.29%	24.80%	-40.88%
EBITDA	-	14.88M	65.98M	41.34M	-3.49M
EBITDA Margin	-	23.50%	54.29%	39.11%	-5.63%
Net Income	-5.14M	10.05M	40.98M	22.15M	-17.37M
Net Income Margin	-45.73%	15.87%	33.72%	20.96%	-28.08%
Interest Expense	150.00K	2.31M	4.48M	4.67M	4.39M
Interest Expense % of Total Revenue	1.33%	3.65%	3.68%	4.42%	7.09%

Balance Sheet

Currency: THB	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	141.25M	151.66M	259.74M	635.69M	598.85M
Total Liabilities	94.97M	95.31M	82.41M	78.11M	70.52M
Total Equity	46.28M	56.35M	177.33M	557.58M	528.34M
Cash	360.00K	22.97M	113.21M	508.51M	467.33M
Net Debt	11.52M	-	-	-	-

Cash Flow

Currency: THB	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	-	61.44M	28.14M	-13.87M
Financing Cash Flow	-	-	60.24M	349.22M	-19.45M
Capital Expenditure	0	0	281.32K	2.45M	46.01K
Free Cash Flow	-	-	61.16M	25.69M	-13.91M
Dividends Paid	-	-	0	31.00M	10.56M
FCF to OCF	-	-	99.54%	91.28%	100.33%
Dividend Paid to FCF	-	-	0.00%	120.67%	-75.91%

Earnings

Report Date	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026
EPS Estimate	-	-	-	-	-	-
EPS Actual	0.02	-0.01	-0.01	-0.01	-0.01	-0.02
Surprise	-	-	-	-	-	-
Timing	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap312.40M

Enterprise Value-69.06M

Trailing P/E0.00

Forward P/E0.00

Price / Sales4.81

Price / Book0.64

EPS-0.03

Book Value1.17

Revenue (TTM)64.97M

Gross Profit (TTM)21.83M

EBITDA-19.26M

Profit Margin-35.59%

Operating Margin-53.76%

Return on Equity-4.41%

Return on Assets-2.81%

Shares Outstanding440.00M

Shares Float193.85M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20251×

0.02Mar 13, 2025